superficial basal cell carcinoma
Showing 1 - 16 of 16
Superficial Basal Cell Carcinoma Trial (Tirbanibulin Ointment 1%)
Not yet recruiting
- Superficial Basal Cell Carcinoma
- Tirbanibulin Ointment 1%
- (no location specified)
Jan 27, 2023
A Patient Decision Aid for Superficial Basal Cell Carcinoma
Completed
- Superficial Basal Cell Carcinoma
- Patient decision aid for patients with superficial basal cell carcinoma
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Centre+
Nov 16, 2022
Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil
Recruiting
- Superficial Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Combination cream of 5-fluorouracil and calcipotriene
- 5-fluorouracil cream
-
Boston, MassachusettsBoston Medical Center Dermatology Clinic
Nov 9, 2022
BCC, BCC - Basal Cell Carcinoma, Basal Cell Carcinoma Trial in New York (drug, procedure, other)
Recruiting
- BCC
- +5 more
- Jet injection of ALA
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 23, 2022
Superficial Basal Cell Carcinoma Trial in United States (Photodynamic therapy (PDT) (ALA-PDT, AmeluzĀ®-PDT), Placebo Photodynamic
Recruiting
- Superficial Basal Cell Carcinoma
- Photodynamic therapy (PDT) (ALA-PDT, AmeluzĀ®-PDT)
- Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)
-
Phoenix, Arizona
- +17 more
Feb 9, 2022
Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma Trial in Aventura, Brandon, Webster (EscharEx 5% (EX-02
Recruiting
- Superficial Basal Cell Carcinoma
- Nodular Basal Cell Carcinoma
- EscharEx 5% (EX-02 formulation)
-
Aventura, Florida
- +2 more
Dec 1, 2021
Basal Cell Carcinoma, Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma Trial in Irvine (1064 nm long-pulse Nd:YAG
Recruiting
- Basal Cell Carcinoma
- +2 more
- 1064 nm long-pulse Nd:YAG laser
-
Irvine, CaliforniaUCI Health Gottschalk Medical Plaza
Feb 4, 2021
Superficial Basal Cell Carcinoma Trial in United States (API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, Placebo)
Completed
- Superficial Basal Cell Carcinoma
- API 31510 3% Topical Cream
- +2 more
-
Hot Springs, Arkansas
- +10 more
Feb 12, 2019
Nodular Basal Cell Carcinoma, Superficial Basal Cell Carcinoma Trial in Miami (595/1064 multiplex laser)
Completed
- Nodular Basal Cell Carcinoma
- Superficial Basal Cell Carcinoma
- 595/1064 multiplex laser
-
Miami, FloridaUniversity of Miami Hospital and Clinics/Sylvester Comprehensive
Oct 1, 2018
Bowen's Disease, Superficial Basal Cell Carcinoma Trial in Ghent (full ablative CO2 laser, fractional ablative CO2 laser, MAL)
Completed
- Bowen's Disease
- Superficial Basal Cell Carcinoma
- full ablative CO2 laser
- +4 more
-
Ghent, BelgiumDepartment of Dermatology, Ghent University Hospital
Jan 24, 2018
Superficial Basal Cell Carcinoma Trial in Australia (PEP005 (ingenol mebutate) Gel, 0.05%, Aluminium disk, OpSite(TM) disk)
Completed
- Superficial Basal Cell Carcinoma
- PEP005 (ingenol mebutate) Gel, 0.05%
- +2 more
-
Kogarah, New South Wales, Australia
- +6 more
Jan 27, 2016
Superficial Basal Cell Carcinoma Trial in Madison (Electrodessication & Curettage)
Terminated
- Superficial Basal Cell Carcinoma
- Electrodessication & Curettage
-
Madison, WisconsinUniversity of Wisconsin-Madison, Department of Dermatology
Feb 25, 2015
Superficial Basal Cell Carcinoma Trial in Maastricht, Venlo, Rotterdam (Methylaminolevulinate PDT in 2 sessions, Fractionated
Unknown status
- Superficial Basal Cell Carcinoma
- Methylaminolevulinate PDT in 2 sessions
- Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
-
Maastricht, Limburg, Netherlands
- +2 more
Jan 30, 2014
Superficial Basal Cell Carcinoma Trial in Worldwide (Cryotherapy or Photodynamic therapy with methyl aminolevulinate cream)
Completed
- Superficial Basal Cell Carcinoma
- Cryotherapy or Photodynamic therapy with methyl aminolevulinate cream
-
Graz, Austria
- +13 more
Sep 1, 2010
Superficial Basal Cell Carcinoma Trial in Australia, New Zealand (Imiquimod 5% cream)
Completed
- Superficial Basal Cell Carcinoma
- Imiquimod 5% cream
-
Concord, New South Wales, Australia
- +17 more
Aug 5, 2010